nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—CYP1A1—lung cancer	0.195	0.653	CbGaD
Clonidine—ABCB1—lung cancer	0.104	0.347	CbGaD
Clonidine—SLC22A3—Irinotecan—lung cancer	0.0458	0.106	CbGbCtD
Clonidine—CYP1A1—Gefitinib—lung cancer	0.0346	0.0799	CbGbCtD
Clonidine—CYP3A5—Gefitinib—lung cancer	0.0208	0.048	CbGbCtD
Clonidine—CYP1A1—Erlotinib—lung cancer	0.0205	0.0473	CbGbCtD
Clonidine—CYP3A5—Teniposide—lung cancer	0.0202	0.0465	CbGbCtD
Clonidine—ABCB1—Topotecan—lung cancer	0.0148	0.0341	CbGbCtD
Clonidine—ABCB1—Gefitinib—lung cancer	0.0135	0.0312	CbGbCtD
Clonidine—CYP2D6—Gefitinib—lung cancer	0.0127	0.0294	CbGbCtD
Clonidine—CYP3A5—Crizotinib—lung cancer	0.0127	0.0294	CbGbCtD
Clonidine—CYP3A5—Erlotinib—lung cancer	0.0123	0.0284	CbGbCtD
Clonidine—CYP3A5—Paclitaxel—lung cancer	0.0112	0.026	CbGbCtD
Clonidine—CYP3A5—Irinotecan—lung cancer	0.0111	0.0256	CbGbCtD
Clonidine—ABCB1—Vinorelbine—lung cancer	0.0104	0.0241	CbGbCtD
Clonidine—CYP2D6—Vinorelbine—lung cancer	0.00982	0.0227	CbGbCtD
Clonidine—CYP1A2—Erlotinib—lung cancer	0.00915	0.0211	CbGbCtD
Clonidine—CYP3A5—Etoposide—lung cancer	0.00889	0.0205	CbGbCtD
Clonidine—CYP3A4—Topotecan—lung cancer	0.00886	0.0205	CbGbCtD
Clonidine—ABCB1—Crizotinib—lung cancer	0.00829	0.0191	CbGbCtD
Clonidine—CYP3A5—Docetaxel—lung cancer	0.00813	0.0188	CbGbCtD
Clonidine—CYP3A4—Gefitinib—lung cancer	0.00811	0.0187	CbGbCtD
Clonidine—ABCB1—Gemcitabine—lung cancer	0.0081	0.0187	CbGbCtD
Clonidine—ABCB1—Erlotinib—lung cancer	0.008	0.0185	CbGbCtD
Clonidine—CYP3A4—Teniposide—lung cancer	0.00786	0.0181	CbGbCtD
Clonidine—CYP2D6—Erlotinib—lung cancer	0.00754	0.0174	CbGbCtD
Clonidine—ABCB1—Paclitaxel—lung cancer	0.00732	0.0169	CbGbCtD
Clonidine—ABCB1—Irinotecan—lung cancer	0.00722	0.0167	CbGbCtD
Clonidine—CYP1A2—Etoposide—lung cancer	0.00662	0.0153	CbGbCtD
Clonidine—ABCB1—Vinblastine—lung cancer	0.00642	0.0148	CbGbCtD
Clonidine—CYP3A4—Vinorelbine—lung cancer	0.00624	0.0144	CbGbCtD
Clonidine—CYP2D6—Vinblastine—lung cancer	0.00605	0.014	CbGbCtD
Clonidine—ABCB1—Cisplatin—lung cancer	0.00589	0.0136	CbGbCtD
Clonidine—ABCB1—Etoposide—lung cancer	0.00579	0.0134	CbGbCtD
Clonidine—ABCB1—Docetaxel—lung cancer	0.00529	0.0122	CbGbCtD
Clonidine—CYP3A4—Crizotinib—lung cancer	0.00497	0.0115	CbGbCtD
Clonidine—CYP3A4—Erlotinib—lung cancer	0.00479	0.0111	CbGbCtD
Clonidine—CYP3A4—Paclitaxel—lung cancer	0.00439	0.0101	CbGbCtD
Clonidine—CYP3A4—Irinotecan—lung cancer	0.00433	0.00999	CbGbCtD
Clonidine—ABCB1—Doxorubicin—lung cancer	0.00395	0.00911	CbGbCtD
Clonidine—CYP3A4—Vinblastine—lung cancer	0.00385	0.00888	CbGbCtD
Clonidine—ABCB1—Methotrexate—lung cancer	0.00382	0.00882	CbGbCtD
Clonidine—CYP2D6—Doxorubicin—lung cancer	0.00372	0.00858	CbGbCtD
Clonidine—CYP3A4—Etoposide—lung cancer	0.00347	0.008	CbGbCtD
Clonidine—CYP3A4—Docetaxel—lung cancer	0.00317	0.00732	CbGbCtD
Clonidine—CYP3A4—Doxorubicin—lung cancer	0.00236	0.00546	CbGbCtD
Clonidine—NISCH—mammary gland—lung cancer	0.00162	0.0756	CbGeAlD
Clonidine—SLC22A4—mammary gland—lung cancer	0.00107	0.05	CbGeAlD
Clonidine—NISCH—Podofilox—Teniposide—lung cancer	0.00093	0.239	CbGdCrCtD
Clonidine—NISCH—bronchus—lung cancer	0.000888	0.0415	CbGeAlD
Clonidine—NISCH—Paclitaxel—Docetaxel—lung cancer	0.000861	0.222	CbGdCrCtD
Clonidine—NISCH—trachea—lung cancer	0.000798	0.0372	CbGeAlD
Clonidine—ADRA1D—epithelium—lung cancer	0.000753	0.0351	CbGeAlD
Clonidine—SLC22A4—respiratory system—lung cancer	0.000714	0.0333	CbGeAlD
Clonidine—SLC22A5—mammary gland—lung cancer	0.000709	0.0331	CbGeAlD
Clonidine—Diclofenac—UGT1A1—lung cancer	0.000664	0.279	CrCbGaD
Clonidine—NISCH—bone marrow—lung cancer	0.000633	0.0295	CbGeAlD
Clonidine—Diclofenac—CXCL8—lung cancer	0.000626	0.263	CrCbGaD
Clonidine—NISCH—Vincristine—Vinorelbine—lung cancer	0.000592	0.152	CbGdCrCtD
Clonidine—SLC22A4—bronchus—lung cancer	0.000587	0.0274	CbGeAlD
Clonidine—NISCH—lung—lung cancer	0.000573	0.0268	CbGeAlD
Clonidine—SLC6A2—respiratory system—lung cancer	0.000557	0.026	CbGeAlD
Clonidine—NISCH—Podofilox—Etoposide—lung cancer	0.000553	0.142	CbGdCrCtD
Clonidine—SLC22A4—trachea—lung cancer	0.000527	0.0246	CbGeAlD
Clonidine—NISCH—Vinblastine—Vinorelbine—lung cancer	0.000476	0.123	CbGdCrCtD
Clonidine—NISCH—Vincristine—Vinblastine—lung cancer	0.000473	0.122	CbGdCrCtD
Clonidine—SLC22A5—respiratory system—lung cancer	0.000472	0.022	CbGeAlD
Clonidine—ADRA1A—epithelium—lung cancer	0.000432	0.0202	CbGeAlD
Clonidine—CYP1A2—respiratory system—lung cancer	0.000428	0.02	CbGeAlD
Clonidine—CYP1A1—respiratory system—lung cancer	0.000422	0.0197	CbGeAlD
Clonidine—SLC22A4—bone marrow—lung cancer	0.000418	0.0195	CbGeAlD
Clonidine—CYP3A5—respiratory system—lung cancer	0.000413	0.0193	CbGeAlD
Clonidine—ADRA2C—bronchus—lung cancer	0.000406	0.0189	CbGeAlD
Clonidine—NISCH—lymph node—lung cancer	0.000392	0.0183	CbGeAlD
Clonidine—SLC22A5—bronchus—lung cancer	0.000389	0.0181	CbGeAlD
Clonidine—SLC22A4—lung—lung cancer	0.000379	0.0177	CbGeAlD
Clonidine—ADRA2C—trachea—lung cancer	0.000364	0.017	CbGeAlD
Clonidine—CYP1A1—epithelium—lung cancer	0.000353	0.0165	CbGeAlD
Clonidine—SLC22A5—trachea—lung cancer	0.000349	0.0163	CbGeAlD
Clonidine—CYP1A1—bronchus—lung cancer	0.000347	0.0162	CbGeAlD
Clonidine—SLC22A3—lung—lung cancer	0.000345	0.0161	CbGeAlD
Clonidine—ADRA2C—cardiac atrium—lung cancer	0.000342	0.016	CbGeAlD
Clonidine—SLC22A5—cardiac atrium—lung cancer	0.000328	0.0153	CbGeAlD
Clonidine—ADRA2A—bronchus—lung cancer	0.000324	0.0151	CbGeAlD
Clonidine—CYP1A1—trachea—lung cancer	0.000312	0.0146	CbGeAlD
Clonidine—Diclofenac—CYP2E1—lung cancer	0.000296	0.125	CrCbGaD
Clonidine—SLC6A2—lung—lung cancer	0.000296	0.0138	CbGeAlD
Clonidine—CYP1A1—cardiac atrium—lung cancer	0.000293	0.0137	CbGeAlD
Clonidine—Diclofenac—CYP1A1—lung cancer	0.000292	0.123	CrCbGaD
Clonidine—ADRA2A—trachea—lung cancer	0.000291	0.0136	CbGeAlD
Clonidine—ADRA2A—cardiac atrium—lung cancer	0.000273	0.0127	CbGeAlD
Clonidine—ADRA2C—lung—lung cancer	0.000262	0.0122	CbGeAlD
Clonidine—SLC22A4—lymph node—lung cancer	0.000259	0.0121	CbGeAlD
Clonidine—SLC22A5—lung—lung cancer	0.000251	0.0117	CbGeAlD
Clonidine—SLC22A3—lymph node—lung cancer	0.000236	0.011	CbGeAlD
Clonidine—CYP1A2—lung—lung cancer	0.000227	0.0106	CbGeAlD
Clonidine—CYP1A1—lung—lung cancer	0.000224	0.0105	CbGeAlD
Clonidine—ABCB1—respiratory system—lung cancer	0.000219	0.0102	CbGeAlD
Clonidine—CYP3A5—lung—lung cancer	0.000219	0.0102	CbGeAlD
Clonidine—ADRA2A—lung—lung cancer	0.000209	0.00975	CbGeAlD
Clonidine—SLC6A2—lymph node—lung cancer	0.000202	0.00943	CbGeAlD
Clonidine—ABCB1—epithelium—lung cancer	0.000183	0.00855	CbGeAlD
Clonidine—Diclofenac—PTGS2—lung cancer	0.000183	0.0768	CrCbGaD
Clonidine—ADRA2C—lymph node—lung cancer	0.000179	0.00836	CbGeAlD
Clonidine—SLC22A5—lymph node—lung cancer	0.000172	0.00801	CbGeAlD
Clonidine—Diclofenac—ALB—lung cancer	0.000163	0.0684	CrCbGaD
Clonidine—ABCB1—trachea—lung cancer	0.000162	0.00756	CbGeAlD
Clonidine—Diclofenac—ABCB1—lung cancer	0.000155	0.0653	CrCbGaD
Clonidine—CYP1A1—lymph node—lung cancer	0.000153	0.00715	CbGeAlD
Clonidine—ADRA2A—lymph node—lung cancer	0.000143	0.00667	CbGeAlD
Clonidine—ABCB1—bone marrow—lung cancer	0.000128	0.006	CbGeAlD
Clonidine—ABCB1—lung—lung cancer	0.000116	0.00543	CbGeAlD
Clonidine—Pain—Cisplatin—lung cancer	8.59e-05	0.000608	CcSEcCtD
Clonidine—Vomiting—Vinorelbine—lung cancer	8.53e-05	0.000604	CcSEcCtD
Clonidine—Body temperature increased—Gemcitabine—lung cancer	8.52e-05	0.000603	CcSEcCtD
Clonidine—Rash—Vinorelbine—lung cancer	8.46e-05	0.000599	CcSEcCtD
Clonidine—Dermatitis—Vinorelbine—lung cancer	8.45e-05	0.000598	CcSEcCtD
Clonidine—Hypotension—Paclitaxel—lung cancer	8.43e-05	0.000597	CcSEcCtD
Clonidine—Headache—Vinorelbine—lung cancer	8.41e-05	0.000595	CcSEcCtD
Clonidine—Syncope—Docetaxel—lung cancer	8.41e-05	0.000595	CcSEcCtD
Clonidine—Asthma—Doxorubicin—lung cancer	8.4e-05	0.000594	CcSEcCtD
Clonidine—Sweating—Methotrexate—lung cancer	8.29e-05	0.000586	CcSEcCtD
Clonidine—Palpitations—Docetaxel—lung cancer	8.28e-05	0.000586	CcSEcCtD
Clonidine—Feeling abnormal—Cisplatin—lung cancer	8.28e-05	0.000586	CcSEcCtD
Clonidine—Paraesthesia—Etoposide—lung cancer	8.27e-05	0.000585	CcSEcCtD
Clonidine—Loss of consciousness—Docetaxel—lung cancer	8.24e-05	0.000583	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Paclitaxel—lung cancer	8.22e-05	0.000582	CcSEcCtD
Clonidine—Dyspnoea—Etoposide—lung cancer	8.21e-05	0.000581	CcSEcCtD
Clonidine—Somnolence—Etoposide—lung cancer	8.18e-05	0.000579	CcSEcCtD
Clonidine—Cough—Docetaxel—lung cancer	8.18e-05	0.000579	CcSEcCtD
Clonidine—Insomnia—Paclitaxel—lung cancer	8.16e-05	0.000578	CcSEcCtD
Clonidine—Epistaxis—Methotrexate—lung cancer	8.15e-05	0.000577	CcSEcCtD
Clonidine—Hypersensitivity—Irinotecan—lung cancer	8.15e-05	0.000577	CcSEcCtD
Clonidine—Paraesthesia—Paclitaxel—lung cancer	8.1e-05	0.000573	CcSEcCtD
Clonidine—Dyspnoea—Paclitaxel—lung cancer	8.05e-05	0.000569	CcSEcCtD
Clonidine—Somnolence—Paclitaxel—lung cancer	8.02e-05	0.000568	CcSEcCtD
Clonidine—Decreased appetite—Etoposide—lung cancer	8e-05	0.000566	CcSEcCtD
Clonidine—Chest pain—Docetaxel—lung cancer	7.98e-05	0.000565	CcSEcCtD
Clonidine—Arthralgia—Docetaxel—lung cancer	7.98e-05	0.000565	CcSEcCtD
Clonidine—Nausea—Vinorelbine—lung cancer	7.97e-05	0.000564	CcSEcCtD
Clonidine—ABCB1—lymph node—lung cancer	7.96e-05	0.00372	CbGeAlD
Clonidine—Gastrointestinal disorder—Etoposide—lung cancer	7.95e-05	0.000562	CcSEcCtD
Clonidine—Body temperature increased—Cisplatin—lung cancer	7.94e-05	0.000562	CcSEcCtD
Clonidine—Asthenia—Irinotecan—lung cancer	7.94e-05	0.000562	CcSEcCtD
Clonidine—Fatigue—Etoposide—lung cancer	7.94e-05	0.000562	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	7.93e-05	0.000561	CcSEcCtD
Clonidine—Pain—Etoposide—lung cancer	7.87e-05	0.000557	CcSEcCtD
Clonidine—Constipation—Etoposide—lung cancer	7.87e-05	0.000557	CcSEcCtD
Clonidine—Dysuria—Doxorubicin—lung cancer	7.85e-05	0.000556	CcSEcCtD
Clonidine—Decreased appetite—Paclitaxel—lung cancer	7.85e-05	0.000555	CcSEcCtD
Clonidine—Dry mouth—Docetaxel—lung cancer	7.81e-05	0.000552	CcSEcCtD
Clonidine—Upper respiratory tract infection—Doxorubicin—lung cancer	7.8e-05	0.000552	CcSEcCtD
Clonidine—Gastrointestinal disorder—Paclitaxel—lung cancer	7.79e-05	0.000551	CcSEcCtD
Clonidine—Fatigue—Paclitaxel—lung cancer	7.78e-05	0.000551	CcSEcCtD
Clonidine—Hepatitis—Methotrexate—lung cancer	7.76e-05	0.000549	CcSEcCtD
Clonidine—Pollakiuria—Doxorubicin—lung cancer	7.76e-05	0.000549	CcSEcCtD
Clonidine—Asthenia—Gemcitabine—lung cancer	7.73e-05	0.000547	CcSEcCtD
Clonidine—Pain—Paclitaxel—lung cancer	7.72e-05	0.000546	CcSEcCtD
Clonidine—Constipation—Paclitaxel—lung cancer	7.72e-05	0.000546	CcSEcCtD
Clonidine—Confusional state—Docetaxel—lung cancer	7.71e-05	0.000546	CcSEcCtD
Clonidine—Oedema—Docetaxel—lung cancer	7.65e-05	0.000541	CcSEcCtD
Clonidine—Weight increased—Doxorubicin—lung cancer	7.64e-05	0.000541	CcSEcCtD
Clonidine—Pruritus—Gemcitabine—lung cancer	7.63e-05	0.00054	CcSEcCtD
Clonidine—Infection—Docetaxel—lung cancer	7.6e-05	0.000538	CcSEcCtD
Clonidine—Feeling abnormal—Etoposide—lung cancer	7.59e-05	0.000537	CcSEcCtD
Clonidine—Diarrhoea—Irinotecan—lung cancer	7.57e-05	0.000536	CcSEcCtD
Clonidine—Gastrointestinal pain—Etoposide—lung cancer	7.53e-05	0.000533	CcSEcCtD
Clonidine—Shock—Docetaxel—lung cancer	7.53e-05	0.000533	CcSEcCtD
Clonidine—Nervous system disorder—Docetaxel—lung cancer	7.5e-05	0.000531	CcSEcCtD
Clonidine—Thrombocytopenia—Docetaxel—lung cancer	7.49e-05	0.00053	CcSEcCtD
Clonidine—Drowsiness—Doxorubicin—lung cancer	7.49e-05	0.00053	CcSEcCtD
Clonidine—Tachycardia—Docetaxel—lung cancer	7.47e-05	0.000528	CcSEcCtD
Clonidine—Feeling abnormal—Paclitaxel—lung cancer	7.44e-05	0.000526	CcSEcCtD
Clonidine—Skin disorder—Docetaxel—lung cancer	7.43e-05	0.000526	CcSEcCtD
Clonidine—Hypersensitivity—Cisplatin—lung cancer	7.4e-05	0.000524	CcSEcCtD
Clonidine—Gastrointestinal pain—Paclitaxel—lung cancer	7.38e-05	0.000522	CcSEcCtD
Clonidine—Diarrhoea—Gemcitabine—lung cancer	7.38e-05	0.000522	CcSEcCtD
Clonidine—Dizziness—Irinotecan—lung cancer	7.32e-05	0.000518	CcSEcCtD
Clonidine—Urticaria—Etoposide—lung cancer	7.31e-05	0.000517	CcSEcCtD
Clonidine—Anorexia—Docetaxel—lung cancer	7.29e-05	0.000516	CcSEcCtD
Clonidine—Abdominal pain—Etoposide—lung cancer	7.28e-05	0.000515	CcSEcCtD
Clonidine—Body temperature increased—Etoposide—lung cancer	7.28e-05	0.000515	CcSEcCtD
Clonidine—Urinary tract infection—Doxorubicin—lung cancer	7.28e-05	0.000515	CcSEcCtD
Clonidine—Eye disorder—Methotrexate—lung cancer	7.25e-05	0.000513	CcSEcCtD
Clonidine—Tinnitus—Methotrexate—lung cancer	7.24e-05	0.000512	CcSEcCtD
Clonidine—Asthenia—Cisplatin—lung cancer	7.21e-05	0.00051	CcSEcCtD
Clonidine—Cardiac disorder—Methotrexate—lung cancer	7.2e-05	0.00051	CcSEcCtD
Clonidine—Sweating—Doxorubicin—lung cancer	7.18e-05	0.000508	CcSEcCtD
Clonidine—Urticaria—Paclitaxel—lung cancer	7.17e-05	0.000507	CcSEcCtD
Clonidine—Hypotension—Docetaxel—lung cancer	7.15e-05	0.000506	CcSEcCtD
Clonidine—Abdominal pain—Paclitaxel—lung cancer	7.14e-05	0.000505	CcSEcCtD
Clonidine—Body temperature increased—Paclitaxel—lung cancer	7.14e-05	0.000505	CcSEcCtD
Clonidine—Epistaxis—Doxorubicin—lung cancer	7.06e-05	0.0005	CcSEcCtD
Clonidine—Angiopathy—Methotrexate—lung cancer	7.04e-05	0.000498	CcSEcCtD
Clonidine—Vomiting—Irinotecan—lung cancer	7.04e-05	0.000498	CcSEcCtD
Clonidine—Mediastinal disorder—Methotrexate—lung cancer	6.99e-05	0.000495	CcSEcCtD
Clonidine—Rash—Irinotecan—lung cancer	6.98e-05	0.000494	CcSEcCtD
Clonidine—Dermatitis—Irinotecan—lung cancer	6.97e-05	0.000493	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Docetaxel—lung cancer	6.97e-05	0.000493	CcSEcCtD
Clonidine—Headache—Irinotecan—lung cancer	6.93e-05	0.000491	CcSEcCtD
Clonidine—Insomnia—Docetaxel—lung cancer	6.92e-05	0.00049	CcSEcCtD
Clonidine—Diarrhoea—Cisplatin—lung cancer	6.88e-05	0.000486	CcSEcCtD
Clonidine—Paraesthesia—Docetaxel—lung cancer	6.87e-05	0.000486	CcSEcCtD
Clonidine—Alopecia—Methotrexate—lung cancer	6.86e-05	0.000485	CcSEcCtD
Clonidine—Vomiting—Gemcitabine—lung cancer	6.85e-05	0.000485	CcSEcCtD
Clonidine—Bradycardia—Doxorubicin—lung cancer	6.84e-05	0.000484	CcSEcCtD
Clonidine—Dyspnoea—Docetaxel—lung cancer	6.82e-05	0.000483	CcSEcCtD
Clonidine—Somnolence—Docetaxel—lung cancer	6.8e-05	0.000481	CcSEcCtD
Clonidine—Mental disorder—Methotrexate—lung cancer	6.8e-05	0.000481	CcSEcCtD
Clonidine—Rash—Gemcitabine—lung cancer	6.8e-05	0.000481	CcSEcCtD
Clonidine—Dermatitis—Gemcitabine—lung cancer	6.79e-05	0.000481	CcSEcCtD
Clonidine—Hypersensitivity—Etoposide—lung cancer	6.78e-05	0.00048	CcSEcCtD
Clonidine—Erythema—Methotrexate—lung cancer	6.76e-05	0.000478	CcSEcCtD
Clonidine—Headache—Gemcitabine—lung cancer	6.75e-05	0.000478	CcSEcCtD
Clonidine—Rhinitis—Doxorubicin—lung cancer	6.74e-05	0.000477	CcSEcCtD
Clonidine—Hepatitis—Doxorubicin—lung cancer	6.72e-05	0.000476	CcSEcCtD
Clonidine—Hypoaesthesia—Doxorubicin—lung cancer	6.69e-05	0.000473	CcSEcCtD
Clonidine—Decreased appetite—Docetaxel—lung cancer	6.65e-05	0.000471	CcSEcCtD
Clonidine—Hypersensitivity—Paclitaxel—lung cancer	6.65e-05	0.000471	CcSEcCtD
Clonidine—Gastrointestinal disorder—Docetaxel—lung cancer	6.6e-05	0.000467	CcSEcCtD
Clonidine—Asthenia—Etoposide—lung cancer	6.6e-05	0.000467	CcSEcCtD
Clonidine—Fatigue—Docetaxel—lung cancer	6.6e-05	0.000467	CcSEcCtD
Clonidine—Nausea—Irinotecan—lung cancer	6.57e-05	0.000465	CcSEcCtD
Clonidine—Pain—Docetaxel—lung cancer	6.54e-05	0.000463	CcSEcCtD
Clonidine—Constipation—Docetaxel—lung cancer	6.54e-05	0.000463	CcSEcCtD
Clonidine—Pruritus—Etoposide—lung cancer	6.51e-05	0.000461	CcSEcCtD
Clonidine—Asthenia—Paclitaxel—lung cancer	6.48e-05	0.000458	CcSEcCtD
Clonidine—Nausea—Gemcitabine—lung cancer	6.4e-05	0.000453	CcSEcCtD
Clonidine—Vomiting—Cisplatin—lung cancer	6.39e-05	0.000452	CcSEcCtD
Clonidine—Pruritus—Paclitaxel—lung cancer	6.39e-05	0.000452	CcSEcCtD
Clonidine—Vision blurred—Methotrexate—lung cancer	6.37e-05	0.000451	CcSEcCtD
Clonidine—Rash—Cisplatin—lung cancer	6.34e-05	0.000448	CcSEcCtD
Clonidine—Dermatitis—Cisplatin—lung cancer	6.33e-05	0.000448	CcSEcCtD
Clonidine—Feeling abnormal—Docetaxel—lung cancer	6.3e-05	0.000446	CcSEcCtD
Clonidine—Diarrhoea—Etoposide—lung cancer	6.3e-05	0.000446	CcSEcCtD
Clonidine—Eye disorder—Doxorubicin—lung cancer	6.28e-05	0.000444	CcSEcCtD
Clonidine—Ill-defined disorder—Methotrexate—lung cancer	6.27e-05	0.000444	CcSEcCtD
Clonidine—Tinnitus—Doxorubicin—lung cancer	6.27e-05	0.000443	CcSEcCtD
Clonidine—Gastrointestinal pain—Docetaxel—lung cancer	6.26e-05	0.000443	CcSEcCtD
Clonidine—Cardiac disorder—Doxorubicin—lung cancer	6.24e-05	0.000441	CcSEcCtD
Clonidine—Diarrhoea—Paclitaxel—lung cancer	6.18e-05	0.000437	CcSEcCtD
Clonidine—Angiopathy—Doxorubicin—lung cancer	6.1e-05	0.000431	CcSEcCtD
Clonidine—Malaise—Methotrexate—lung cancer	6.09e-05	0.000431	CcSEcCtD
Clonidine—Dizziness—Etoposide—lung cancer	6.09e-05	0.000431	CcSEcCtD
Clonidine—Mediastinal disorder—Doxorubicin—lung cancer	6.06e-05	0.000429	CcSEcCtD
Clonidine—Abdominal pain—Docetaxel—lung cancer	6.05e-05	0.000428	CcSEcCtD
Clonidine—Body temperature increased—Docetaxel—lung cancer	6.05e-05	0.000428	CcSEcCtD
Clonidine—Arrhythmia—Doxorubicin—lung cancer	6e-05	0.000425	CcSEcCtD
Clonidine—Dizziness—Paclitaxel—lung cancer	5.97e-05	0.000422	CcSEcCtD
Clonidine—Nausea—Cisplatin—lung cancer	5.97e-05	0.000422	CcSEcCtD
Clonidine—Alopecia—Doxorubicin—lung cancer	5.94e-05	0.00042	CcSEcCtD
Clonidine—Cough—Methotrexate—lung cancer	5.9e-05	0.000417	CcSEcCtD
Clonidine—Mental disorder—Doxorubicin—lung cancer	5.89e-05	0.000417	CcSEcCtD
Clonidine—Vomiting—Etoposide—lung cancer	5.85e-05	0.000414	CcSEcCtD
Clonidine—Erythema—Doxorubicin—lung cancer	5.85e-05	0.000414	CcSEcCtD
Clonidine—Rash—Etoposide—lung cancer	5.8e-05	0.000411	CcSEcCtD
Clonidine—Dermatitis—Etoposide—lung cancer	5.8e-05	0.00041	CcSEcCtD
Clonidine—Headache—Etoposide—lung cancer	5.77e-05	0.000408	CcSEcCtD
Clonidine—Arthralgia—Methotrexate—lung cancer	5.75e-05	0.000407	CcSEcCtD
Clonidine—Chest pain—Methotrexate—lung cancer	5.75e-05	0.000407	CcSEcCtD
Clonidine—Tension—Doxorubicin—lung cancer	5.74e-05	0.000406	CcSEcCtD
Clonidine—Vomiting—Paclitaxel—lung cancer	5.74e-05	0.000406	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	5.71e-05	0.000404	CcSEcCtD
Clonidine—Rash—Paclitaxel—lung cancer	5.69e-05	0.000403	CcSEcCtD
Clonidine—Dermatitis—Paclitaxel—lung cancer	5.69e-05	0.000402	CcSEcCtD
Clonidine—Discomfort—Methotrexate—lung cancer	5.68e-05	0.000402	CcSEcCtD
Clonidine—Nervousness—Doxorubicin—lung cancer	5.68e-05	0.000402	CcSEcCtD
Clonidine—Headache—Paclitaxel—lung cancer	5.65e-05	0.0004	CcSEcCtD
Clonidine—Hypersensitivity—Docetaxel—lung cancer	5.64e-05	0.000399	CcSEcCtD
Clonidine—Muscle spasms—Doxorubicin—lung cancer	5.62e-05	0.000398	CcSEcCtD
Clonidine—Confusional state—Methotrexate—lung cancer	5.56e-05	0.000393	CcSEcCtD
Clonidine—Vision blurred—Doxorubicin—lung cancer	5.51e-05	0.00039	CcSEcCtD
Clonidine—Asthenia—Docetaxel—lung cancer	5.49e-05	0.000388	CcSEcCtD
Clonidine—Infection—Methotrexate—lung cancer	5.48e-05	0.000388	CcSEcCtD
Clonidine—Nausea—Etoposide—lung cancer	5.47e-05	0.000387	CcSEcCtD
Clonidine—Ill-defined disorder—Doxorubicin—lung cancer	5.43e-05	0.000384	CcSEcCtD
Clonidine—Pruritus—Docetaxel—lung cancer	5.41e-05	0.000383	CcSEcCtD
Clonidine—Nervous system disorder—Methotrexate—lung cancer	5.41e-05	0.000383	CcSEcCtD
Clonidine—Thrombocytopenia—Methotrexate—lung cancer	5.4e-05	0.000382	CcSEcCtD
Clonidine—Agitation—Doxorubicin—lung cancer	5.38e-05	0.00038	CcSEcCtD
Clonidine—Nausea—Paclitaxel—lung cancer	5.36e-05	0.000379	CcSEcCtD
Clonidine—Skin disorder—Methotrexate—lung cancer	5.36e-05	0.000379	CcSEcCtD
Clonidine—Hyperhidrosis—Methotrexate—lung cancer	5.33e-05	0.000377	CcSEcCtD
Clonidine—Malaise—Doxorubicin—lung cancer	5.28e-05	0.000373	CcSEcCtD
Clonidine—Anorexia—Methotrexate—lung cancer	5.26e-05	0.000372	CcSEcCtD
Clonidine—Syncope—Doxorubicin—lung cancer	5.25e-05	0.000371	CcSEcCtD
Clonidine—Diarrhoea—Docetaxel—lung cancer	5.23e-05	0.00037	CcSEcCtD
Clonidine—Palpitations—Doxorubicin—lung cancer	5.17e-05	0.000366	CcSEcCtD
Clonidine—Hypotension—Methotrexate—lung cancer	5.15e-05	0.000365	CcSEcCtD
Clonidine—Loss of consciousness—Doxorubicin—lung cancer	5.14e-05	0.000364	CcSEcCtD
Clonidine—Cough—Doxorubicin—lung cancer	5.11e-05	0.000361	CcSEcCtD
Clonidine—Dizziness—Docetaxel—lung cancer	5.06e-05	0.000358	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Methotrexate—lung cancer	5.02e-05	0.000355	CcSEcCtD
Clonidine—Insomnia—Methotrexate—lung cancer	4.99e-05	0.000353	CcSEcCtD
Clonidine—Chest pain—Doxorubicin—lung cancer	4.98e-05	0.000352	CcSEcCtD
Clonidine—Arthralgia—Doxorubicin—lung cancer	4.98e-05	0.000352	CcSEcCtD
Clonidine—Anxiety—Doxorubicin—lung cancer	4.96e-05	0.000351	CcSEcCtD
Clonidine—Paraesthesia—Methotrexate—lung cancer	4.95e-05	0.00035	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	4.95e-05	0.00035	CcSEcCtD
Clonidine—Discomfort—Doxorubicin—lung cancer	4.92e-05	0.000348	CcSEcCtD
Clonidine—Dyspnoea—Methotrexate—lung cancer	4.92e-05	0.000348	CcSEcCtD
Clonidine—Somnolence—Methotrexate—lung cancer	4.9e-05	0.000347	CcSEcCtD
Clonidine—Dry mouth—Doxorubicin—lung cancer	4.87e-05	0.000345	CcSEcCtD
Clonidine—Vomiting—Docetaxel—lung cancer	4.86e-05	0.000344	CcSEcCtD
Clonidine—Rash—Docetaxel—lung cancer	4.82e-05	0.000341	CcSEcCtD
Clonidine—Dermatitis—Docetaxel—lung cancer	4.82e-05	0.000341	CcSEcCtD
Clonidine—Confusional state—Doxorubicin—lung cancer	4.81e-05	0.000341	CcSEcCtD
Clonidine—Decreased appetite—Methotrexate—lung cancer	4.79e-05	0.000339	CcSEcCtD
Clonidine—Headache—Docetaxel—lung cancer	4.79e-05	0.000339	CcSEcCtD
Clonidine—Oedema—Doxorubicin—lung cancer	4.77e-05	0.000338	CcSEcCtD
Clonidine—Gastrointestinal disorder—Methotrexate—lung cancer	4.76e-05	0.000337	CcSEcCtD
Clonidine—Fatigue—Methotrexate—lung cancer	4.75e-05	0.000336	CcSEcCtD
Clonidine—Infection—Doxorubicin—lung cancer	4.74e-05	0.000336	CcSEcCtD
Clonidine—Pain—Methotrexate—lung cancer	4.72e-05	0.000334	CcSEcCtD
Clonidine—Shock—Doxorubicin—lung cancer	4.7e-05	0.000332	CcSEcCtD
Clonidine—Nervous system disorder—Doxorubicin—lung cancer	4.68e-05	0.000331	CcSEcCtD
Clonidine—Thrombocytopenia—Doxorubicin—lung cancer	4.67e-05	0.000331	CcSEcCtD
Clonidine—Tachycardia—Doxorubicin—lung cancer	4.66e-05	0.00033	CcSEcCtD
Clonidine—Skin disorder—Doxorubicin—lung cancer	4.64e-05	0.000328	CcSEcCtD
Clonidine—Hyperhidrosis—Doxorubicin—lung cancer	4.62e-05	0.000327	CcSEcCtD
Clonidine—Anorexia—Doxorubicin—lung cancer	4.55e-05	0.000322	CcSEcCtD
Clonidine—Nausea—Docetaxel—lung cancer	4.54e-05	0.000322	CcSEcCtD
Clonidine—Feeling abnormal—Methotrexate—lung cancer	4.54e-05	0.000322	CcSEcCtD
Clonidine—Gastrointestinal pain—Methotrexate—lung cancer	4.51e-05	0.000319	CcSEcCtD
Clonidine—Hypotension—Doxorubicin—lung cancer	4.46e-05	0.000316	CcSEcCtD
Clonidine—Urticaria—Methotrexate—lung cancer	4.38e-05	0.00031	CcSEcCtD
Clonidine—Abdominal pain—Methotrexate—lung cancer	4.36e-05	0.000308	CcSEcCtD
Clonidine—Body temperature increased—Methotrexate—lung cancer	4.36e-05	0.000308	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Doxorubicin—lung cancer	4.35e-05	0.000308	CcSEcCtD
Clonidine—Insomnia—Doxorubicin—lung cancer	4.32e-05	0.000306	CcSEcCtD
Clonidine—Paraesthesia—Doxorubicin—lung cancer	4.29e-05	0.000303	CcSEcCtD
Clonidine—Dyspnoea—Doxorubicin—lung cancer	4.26e-05	0.000301	CcSEcCtD
Clonidine—Somnolence—Doxorubicin—lung cancer	4.24e-05	0.0003	CcSEcCtD
Clonidine—Decreased appetite—Doxorubicin—lung cancer	4.15e-05	0.000294	CcSEcCtD
Clonidine—Gastrointestinal disorder—Doxorubicin—lung cancer	4.12e-05	0.000292	CcSEcCtD
Clonidine—Fatigue—Doxorubicin—lung cancer	4.12e-05	0.000291	CcSEcCtD
Clonidine—Constipation—Doxorubicin—lung cancer	4.08e-05	0.000289	CcSEcCtD
Clonidine—Pain—Doxorubicin—lung cancer	4.08e-05	0.000289	CcSEcCtD
Clonidine—Hypersensitivity—Methotrexate—lung cancer	4.06e-05	0.000287	CcSEcCtD
Clonidine—Asthenia—Methotrexate—lung cancer	3.96e-05	0.00028	CcSEcCtD
Clonidine—Feeling abnormal—Doxorubicin—lung cancer	3.93e-05	0.000278	CcSEcCtD
Clonidine—Gastrointestinal pain—Doxorubicin—lung cancer	3.9e-05	0.000276	CcSEcCtD
Clonidine—Pruritus—Methotrexate—lung cancer	3.9e-05	0.000276	CcSEcCtD
Clonidine—Urticaria—Doxorubicin—lung cancer	3.79e-05	0.000268	CcSEcCtD
Clonidine—Abdominal pain—Doxorubicin—lung cancer	3.77e-05	0.000267	CcSEcCtD
Clonidine—Body temperature increased—Doxorubicin—lung cancer	3.77e-05	0.000267	CcSEcCtD
Clonidine—Diarrhoea—Methotrexate—lung cancer	3.77e-05	0.000267	CcSEcCtD
Clonidine—Dizziness—Methotrexate—lung cancer	3.65e-05	0.000258	CcSEcCtD
Clonidine—Hypersensitivity—Doxorubicin—lung cancer	3.52e-05	0.000249	CcSEcCtD
Clonidine—Vomiting—Methotrexate—lung cancer	3.51e-05	0.000248	CcSEcCtD
Clonidine—Rash—Methotrexate—lung cancer	3.48e-05	0.000246	CcSEcCtD
Clonidine—Dermatitis—Methotrexate—lung cancer	3.47e-05	0.000246	CcSEcCtD
Clonidine—Headache—Methotrexate—lung cancer	3.45e-05	0.000244	CcSEcCtD
Clonidine—Asthenia—Doxorubicin—lung cancer	3.43e-05	0.000242	CcSEcCtD
Clonidine—Pruritus—Doxorubicin—lung cancer	3.38e-05	0.000239	CcSEcCtD
Clonidine—Nausea—Methotrexate—lung cancer	3.28e-05	0.000232	CcSEcCtD
Clonidine—Diarrhoea—Doxorubicin—lung cancer	3.27e-05	0.000231	CcSEcCtD
Clonidine—Dizziness—Doxorubicin—lung cancer	3.16e-05	0.000223	CcSEcCtD
Clonidine—Vomiting—Doxorubicin—lung cancer	3.04e-05	0.000215	CcSEcCtD
Clonidine—Rash—Doxorubicin—lung cancer	3.01e-05	0.000213	CcSEcCtD
Clonidine—Dermatitis—Doxorubicin—lung cancer	3.01e-05	0.000213	CcSEcCtD
Clonidine—Headache—Doxorubicin—lung cancer	2.99e-05	0.000212	CcSEcCtD
Clonidine—Nausea—Doxorubicin—lung cancer	2.84e-05	0.000201	CcSEcCtD
Clonidine—ADRA1B—Signaling Pathways—PIK3CB—lung cancer	2.91e-06	2.94e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IL2—lung cancer	2.91e-06	2.93e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CREBBP—lung cancer	2.91e-06	2.93e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—KRAS—lung cancer	2.91e-06	2.93e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—IL6—lung cancer	2.9e-06	2.92e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—EP300—lung cancer	2.89e-06	2.92e-05	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—AKT1—lung cancer	2.89e-06	2.91e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PIK3CB—lung cancer	2.88e-06	2.9e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ABCB1—lung cancer	2.87e-06	2.9e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—EGFR—lung cancer	2.86e-06	2.88e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CD—lung cancer	2.86e-06	2.88e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PTGS2—lung cancer	2.85e-06	2.87e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CXCL8—lung cancer	2.84e-06	2.87e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—APOA1—lung cancer	2.84e-06	2.87e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP2E1—lung cancer	2.84e-06	2.86e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CCND1—lung cancer	2.84e-06	2.86e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—JUN—lung cancer	2.83e-06	2.85e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—HRAS—lung cancer	2.83e-06	2.85e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—TYMS—lung cancer	2.82e-06	2.85e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—ALB—lung cancer	2.82e-06	2.84e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—SRC—lung cancer	2.81e-06	2.84e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—NQO1—lung cancer	2.81e-06	2.83e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CXCL8—lung cancer	2.8e-06	2.82e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—EP300—lung cancer	2.8e-06	2.82e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—GSTM1—lung cancer	2.79e-06	2.81e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—HRAS—lung cancer	2.78e-06	2.8e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MAP2K1—lung cancer	2.78e-06	2.8e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CD—lung cancer	2.76e-06	2.78e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MMP9—lung cancer	2.75e-06	2.78e-05	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—AKT1—lung cancer	2.75e-06	2.77e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CDKN1A—lung cancer	2.74e-06	2.77e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—VEGFA—lung cancer	2.74e-06	2.76e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PTEN—lung cancer	2.74e-06	2.76e-05	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—PIK3CA—lung cancer	2.73e-06	2.75e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CASP3—lung cancer	2.72e-06	2.74e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IL2—lung cancer	2.72e-06	2.74e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—STAT3—lung cancer	2.71e-06	2.73e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—NRAS—lung cancer	2.71e-06	2.73e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—IL6—lung cancer	2.71e-06	2.73e-05	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—AKT1—lung cancer	2.7e-06	2.73e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—KRAS—lung cancer	2.7e-06	2.72e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CASP3—lung cancer	2.68e-06	2.7e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—APOA1—lung cancer	2.68e-06	2.7e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IL2—lung cancer	2.68e-06	2.7e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—AKT1—lung cancer	2.67e-06	2.69e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—PIK3CA—lung cancer	2.67e-06	2.69e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—IL6—lung cancer	2.66e-06	2.68e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MDM2—lung cancer	2.66e-06	2.68e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—RAF1—lung cancer	2.65e-06	2.67e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CCND1—lung cancer	2.65e-06	2.67e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CYP1A1—lung cancer	2.64e-06	2.67e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—JUN—lung cancer	2.64e-06	2.67e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3CB—lung cancer	2.64e-06	2.66e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ERCC2—lung cancer	2.62e-06	2.64e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—ERBB2—lung cancer	2.62e-06	2.64e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—EP300—lung cancer	2.61e-06	2.63e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PTGS2—lung cancer	2.61e-06	2.63e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CCND1—lung cancer	2.61e-06	2.63e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—JUN—lung cancer	2.6e-06	2.62e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CG—lung cancer	2.6e-06	2.62e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MAPK3—lung cancer	2.59e-06	2.61e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MTOR—lung cancer	2.59e-06	2.61e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3CB—lung cancer	2.59e-06	2.61e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MMP9—lung cancer	2.57e-06	2.59e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CDKN1A—lung cancer	2.56e-06	2.58e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PTEN—lung cancer	2.56e-06	2.58e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—SRC—lung cancer	2.54e-06	2.56e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MMP9—lung cancer	2.53e-06	2.55e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—STK11—lung cancer	2.53e-06	2.55e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CDKN1A—lung cancer	2.52e-06	2.54e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MYC—lung cancer	2.52e-06	2.54e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PTEN—lung cancer	2.52e-06	2.54e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—AKT1—lung cancer	2.5e-06	2.52e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CB—lung cancer	2.49e-06	2.51e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CXCL8—lung cancer	2.49e-06	2.51e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PTEN—lung cancer	2.48e-06	2.5e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—PIK3CA—lung cancer	2.48e-06	2.5e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—VEGFA—lung cancer	2.47e-06	2.49e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MDM2—lung cancer	2.47e-06	2.49e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—HRAS—lung cancer	2.47e-06	2.49e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—POMC—lung cancer	2.47e-06	2.49e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PTGS2—lung cancer	2.47e-06	2.49e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—EGFR—lung cancer	2.47e-06	2.49e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—RAF1—lung cancer	2.46e-06	2.48e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—AKT1—lung cancer	2.46e-06	2.48e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—STAT3—lung cancer	2.45e-06	2.47e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CG—lung cancer	2.45e-06	2.47e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NRAS—lung cancer	2.44e-06	2.46e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—EP300—lung cancer	2.44e-06	2.46e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—ERBB2—lung cancer	2.44e-06	2.46e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CREBBP—lung cancer	2.41e-06	2.43e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CB—lung cancer	2.4e-06	2.42e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MTOR—lung cancer	2.4e-06	2.42e-05	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—AKT1—lung cancer	2.4e-06	2.42e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—EP300—lung cancer	2.4e-06	2.42e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CASP3—lung cancer	2.38e-06	2.4e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IL2—lung cancer	2.38e-06	2.4e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—SRC—lung cancer	2.37e-06	2.39e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—EP300—lung cancer	2.37e-06	2.39e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—IL6—lung cancer	2.36e-06	2.38e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GSTP1—lung cancer	2.34e-06	2.36e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MAPK3—lung cancer	2.34e-06	2.36e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—SRC—lung cancer	2.33e-06	2.35e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—KRAS—lung cancer	2.33e-06	2.35e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—POMC—lung cancer	2.33e-06	2.35e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CCND1—lung cancer	2.32e-06	2.34e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—JUN—lung cancer	2.31e-06	2.33e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CXCL8—lung cancer	2.31e-06	2.33e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—VEGFA—lung cancer	2.31e-06	2.33e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—HRAS—lung cancer	2.3e-06	2.31e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—STAT3—lung cancer	2.29e-06	2.31e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NRAS—lung cancer	2.28e-06	2.3e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CD—lung cancer	2.28e-06	2.3e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CAT—lung cancer	2.28e-06	2.3e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PTEN—lung cancer	2.28e-06	2.3e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MYC—lung cancer	2.28e-06	2.29e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—VEGFA—lung cancer	2.27e-06	2.29e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—APOA1—lung cancer	2.27e-06	2.29e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CREBBP—lung cancer	2.27e-06	2.29e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—ALB—lung cancer	2.25e-06	2.27e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—STAT3—lung cancer	2.25e-06	2.27e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MMP9—lung cancer	2.25e-06	2.27e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NRAS—lung cancer	2.25e-06	2.26e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CDKN1A—lung cancer	2.24e-06	2.26e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PTEN—lung cancer	2.24e-06	2.25e-05	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—AKT1—lung cancer	2.23e-06	2.25e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—EGFR—lung cancer	2.23e-06	2.24e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ABCB1—lung cancer	2.22e-06	2.24e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CASP3—lung cancer	2.21e-06	2.23e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IL2—lung cancer	2.21e-06	2.23e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—IL6—lung cancer	2.2e-06	2.21e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MAPK3—lung cancer	2.19e-06	2.2e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—AKT1—lung cancer	2.18e-06	2.2e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—TYMS—lung cancer	2.18e-06	2.2e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.17e-06	2.19e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—EP300—lung cancer	2.17e-06	2.19e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PIK3CA—lung cancer	2.16e-06	2.18e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GSTM1—lung cancer	2.15e-06	2.17e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CCND1—lung cancer	2.15e-06	2.17e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PTEN—lung cancer	2.15e-06	2.17e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MAPK3—lung cancer	2.15e-06	2.17e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CD—lung cancer	2.15e-06	2.17e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—JUN—lung cancer	2.15e-06	2.17e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—PIK3CA—lung cancer	2.14e-06	2.16e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—EP300—lung cancer	2.13e-06	2.15e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MYC—lung cancer	2.13e-06	2.14e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—ALB—lung cancer	2.12e-06	2.14e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—KRAS—lung cancer	2.1e-06	2.12e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MYC—lung cancer	2.09e-06	2.11e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MMP9—lung cancer	2.09e-06	2.11e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CDKN1A—lung cancer	2.08e-06	2.1e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—EGFR—lung cancer	2.08e-06	2.1e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PTEN—lung cancer	2.08e-06	2.09e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—SRC—lung cancer	2.07e-06	2.09e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CG—lung cancer	2.07e-06	2.09e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TP53—lung cancer	2.07e-06	2.09e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PIK3CA—lung cancer	2.07e-06	2.08e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—EP300—lung cancer	2.05e-06	2.07e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—EGFR—lung cancer	2.05e-06	2.06e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYP1A1—lung cancer	2.04e-06	2.06e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—AKT1—lung cancer	2.03e-06	2.04e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ERCC2—lung cancer	2.02e-06	2.04e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—VEGFA—lung cancer	2.02e-06	2.04e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—STAT3—lung cancer	2e-06	2.02e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NRAS—lung cancer	2e-06	2.01e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CB—lung cancer	1.99e-06	2e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—EP300—lung cancer	1.98e-06	2e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—HRAS—lung cancer	1.98e-06	2e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—POMC—lung cancer	1.97e-06	1.99e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PTGS2—lung cancer	1.97e-06	1.99e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—KRAS—lung cancer	1.96e-06	1.98e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—KRAS—lung cancer	1.93e-06	1.95e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PIK3CA—lung cancer	1.93e-06	1.95e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—SRC—lung cancer	1.93e-06	1.94e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CREBBP—lung cancer	1.92e-06	1.94e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MAPK3—lung cancer	1.91e-06	1.93e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—IL6—lung cancer	1.89e-06	1.91e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—VEGFA—lung cancer	1.88e-06	1.89e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CB—lung cancer	1.87e-06	1.89e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TP53—lung cancer	1.87e-06	1.88e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MYC—lung cancer	1.86e-06	1.87e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—STAT3—lung cancer	1.86e-06	1.87e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PTGS2—lung cancer	1.86e-06	1.87e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NRAS—lung cancer	1.85e-06	1.87e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CD—lung cancer	1.82e-06	1.84e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—EGFR—lung cancer	1.82e-06	1.83e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PIK3CA—lung cancer	1.8e-06	1.82e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ALB—lung cancer	1.8e-06	1.81e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—HRAS—lung cancer	1.79e-06	1.8e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PIK3CA—lung cancer	1.78e-06	1.79e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MAPK3—lung cancer	1.78e-06	1.79e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—AKT1—lung cancer	1.76e-06	1.78e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PIK3CA—lung cancer	1.75e-06	1.77e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—APOA1—lung cancer	1.75e-06	1.77e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—AKT1—lung cancer	1.75e-06	1.76e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TP53—lung cancer	1.75e-06	1.76e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MYC—lung cancer	1.73e-06	1.74e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PTEN—lung cancer	1.72e-06	1.73e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TP53—lung cancer	1.72e-06	1.73e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—KRAS—lung cancer	1.72e-06	1.73e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IL6—lung cancer	1.71e-06	1.72e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—AKT1—lung cancer	1.69e-06	1.7e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—EGFR—lung cancer	1.69e-06	1.7e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—HRAS—lung cancer	1.67e-06	1.68e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—HRAS—lung cancer	1.64e-06	1.66e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—EP300—lung cancer	1.64e-06	1.65e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PTEN—lung cancer	1.62e-06	1.63e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3CA—lung cancer	1.61e-06	1.62e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CG—lung cancer	1.6e-06	1.61e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IL6—lung cancer	1.6e-06	1.61e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—KRAS—lung cancer	1.6e-06	1.61e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CB—lung cancer	1.59e-06	1.6e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—AKT1—lung cancer	1.58e-06	1.59e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3CA—lung cancer	1.58e-06	1.59e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PTGS2—lung cancer	1.57e-06	1.59e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IL6—lung cancer	1.57e-06	1.59e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—EP300—lung cancer	1.54e-06	1.56e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TP53—lung cancer	1.53e-06	1.54e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—POMC—lung cancer	1.52e-06	1.53e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CA—lung cancer	1.52e-06	1.53e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CREBBP—lung cancer	1.48e-06	1.49e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—AKT1—lung cancer	1.47e-06	1.49e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CA—lung cancer	1.47e-06	1.48e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—HRAS—lung cancer	1.46e-06	1.47e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—AKT1—lung cancer	1.45e-06	1.46e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—AKT1—lung cancer	1.43e-06	1.44e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TP53—lung cancer	1.42e-06	1.43e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CD—lung cancer	1.41e-06	1.42e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IL6—lung cancer	1.4e-06	1.41e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ALB—lung cancer	1.39e-06	1.4e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PTEN—lung cancer	1.37e-06	1.38e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—HRAS—lung cancer	1.36e-06	1.37e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—AKT1—lung cancer	1.31e-06	1.32e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—EP300—lung cancer	1.31e-06	1.32e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IL6—lung cancer	1.3e-06	1.31e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—AKT1—lung cancer	1.29e-06	1.3e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—AKT1—lung cancer	1.24e-06	1.25e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CB—lung cancer	1.23e-06	1.24e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PTGS2—lung cancer	1.21e-06	1.22e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CA—lung cancer	1.21e-06	1.22e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—AKT1—lung cancer	1.2e-06	1.21e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CA—lung cancer	1.14e-06	1.15e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PTEN—lung cancer	1.06e-06	1.07e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—EP300—lung cancer	1.01e-06	1.02e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—AKT1—lung cancer	9.9e-07	9.98e-06	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CA—lung cancer	9.68e-07	9.76e-06	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—AKT1—lung cancer	9.33e-07	9.41e-06	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—AKT1—lung cancer	7.91e-07	7.97e-06	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CA—lung cancer	7.47e-07	7.53e-06	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—AKT1—lung cancer	6.1e-07	6.15e-06	CbGpPWpGaD
